Connect with us

JAMMU & KASHMIR

DAK skeptical of Russian COVID-19 vaccine | KNO

Published

on

kno news

Srinagar, Aug 12 (KNO): While Russia has approved the world’s first COVID-19 vaccine for public use, Doctors Association Kashmir (DAK) on Wednesday said they are skeptical about the claim as the vaccine has been granted license for civilian use even before the clinical trials are completed. “Mass vaccination with an incompletely tested vaccine is unethical,” said DAK President and influenza expert Dr Nisar ul Hassan in a statement issued to the news agency—Kashmir News Observer (KNO). “Russia has conducted just two trials of the vaccine with the third clinical trial yet to start,” he said. “The normal approval process of a new vaccine is to gather data from phase 1 and phase 2 clinical trials and then expand the pool of study participants in phase 3 to create enough evidence that the vaccine is effective and safe. Dr Nisar said to fully assess the efficacy and safety of a vaccine phase 3 trials are required. “The phase 3 trial is the pivotal study on which the decision on whether to grant the license is based,” he said. He said Russia has not made data from the earlier trials public and the data has not been peer-reviewed which is important for regulatory approval. “Lack of published data on vaccine - including how it is made and details on safety, immune response and whether it can prevent COVID-19 infection has left health experts and the public across the globe in dark,” he added. Dr Nisar said the rush to start using the vaccine before phase 3 trials, which normally lasts for months and involve thousands of people could backfire. “One of the biggest concerns about approving a new vaccine before clinical trials are complete is that it could jeopardize public trust in the vaccine development process and people may not use it,” he said. “Even the Moscow-based Association of Clinical Trials Organization, a trade body representing the world’s top drug makers in Russia had urged the Russian health ministry to postpone vaccine approval until the final trial is successfully completed. The World Health Organization has made it clear that any WHO stamp of approval on Russia’s COVID-19 vaccine would require a rigorous safety data review,” said Dr Nisar—(KNO) 

Trending

TOP STORIES7 hours ago

Companies in J&K must prioritise hiring local youth: CM Omar | KNO

TOP STORIES7 hours ago

Kupwara schoolgirl’s death: Education Minister assures justice, action against officials | KNO

TOP STORIES7 hours ago

Technology can transform healthcare, improve early cancer detection: Sakeena Itoo | KNO

TOP STORIES7 hours ago

Deputy CM snubs MLA Kangan, avoids handshake at Jammu event | KNO

TOP STORIES7 hours ago

Five new GMCs’ employees continue protest over pending service rules | KNO

TOP STORIES7 hours ago

Multiple marriages, extortion: Main accused held in Baramulla racket | KNO

TOP STORIES7 hours ago

J&K moving towards normalcy, but challenges remain, says SDG CRPF | KNO

TOP STORIES7 hours ago

Srinagar records season’s first sub-zero night, mercury drops to -0.1°C | KNO

TOP STORIES7 hours ago

Migratory birds start landing in Kashmir, Census soon | KNO

TOP STORIES7 hours ago

Milestone for Ladakh: Black-necked crane population reaches 108 in 2026, registers 25% rise from 2025 | KNO

TOP STORIES7 hours ago

Ladakh records 66% rise in tourist arrivals in first 10 months of 2026 | KNO

TOP STORIES7 hours ago

CRPF Cup: 8 matches played in Srinagar on 2nd day | KNO

TOP STORIES7 hours ago

MLA Lal Chowk Pardesi extends Rs 12.25 lakh relief to 21 fire-hit families | KNO

TOP STORIES8 hours ago

J&K Bank takes smart learning to 27 Army schools, upgrades 127 classrooms | KNO

TOP STORIES8 hours ago

Naming school after Gaziya will keep her memory alive: NC's Rabia Wani | KNO

TOP STORIES8 hours ago

Rs 601 Cr Ayushman Bharat claims pending in J&K, Health Department tells Assembly Panel | KNO

TOP STORIES8 hours ago

ACB chargesheets 15 in Rajouri ration case, says loss to exchequer exceeds Rs 50 lakh | KNO

Copyright © 2021